Biomoda (BMOD $.18) Signs Research Agreement with Saccomanno Research Institute
ALBUQUERQUE, N.M., Sep 07, 2010 (BUSINESS WIRE) -- Cancer diagnostics company Biomoda, Inc. (BMOD) (http://www.biomoda.com) is working with the Saccomanno Research Institute to advance Biomoda's patented system for measuring the photon emission rate of CyPath(R)-stained cells to detect early-stage lung cancer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.